Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
Titel:
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
Auteur:
McCarthy, James S Lotharius, Julie Rückle, Thomas Chalon, Stephan Phillips, Margaret A Elliott, Suzanne Sekuloski, Silvana Griffin, Paul Ng, Caroline L Fidock, David A Marquart, Louise Williams, Noelle S Gobeau, Nathalie Bebrevska, Lidiya Rosario, Maria Marsh, Kennan Möhrle, Jörg J
Verschenen in:
The lancet infectious diseases
Paginering:
Jaargang 17 (2017) nr. 6 pagina's 10 p.
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license